Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C (2022)
Attributed to:
Core Capability for Chemistry Research in Southampton
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsptsci.2c00164
PubMed Identifier: 36407959
Publication URI: http://europepmc.org/abstract/MED/36407959
Type: Journal Article/Review
Parent Publication: ACS Pharmacology & Translational Science
Issue: 11
ISSN: 2575-9108